• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲胎蛋白、凝集素反应性甲胎蛋白和去γ-羧基凝血酶原在乙型肝炎病毒相关肝细胞癌中的诊断价值。

Diagnostic value of alpha-fetoprotein, agglutinin-reactive alpha-fetoprotein, and des-gamma-carboxyprothrombin in hepatitis B virus-related hepatocellular carcinoma.

机构信息

Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.

Beijing Key Laboratory for HIV/AIDS Research, Beijing, China.

出版信息

J Int Med Res. 2020 Mar;48(3):300060519889270. doi: 10.1177/0300060519889270. Epub 2019 Dec 18.

DOI:10.1177/0300060519889270
PMID:31852373
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7604992/
Abstract

OBJECTIVE

This study aimed to explore the use of different combinations of alpha-fetoprotein (AFP), agglutinin-reactive AFP (AFP-L3), and des-gamma-carboxyprothrombin (DCP) for the early diagnosis of hepatocellular carcinoma (HCC) in patients with hepatitis B virus (HBV)-associated liver cirrhosis (LC).

METHODS

There were 167 subjects, including 100 with HCC and 67 with LC, who were enrolled into this study. Serum AFP, AFP-L3, and DCP levels were detected by chemiluminescent enzyme immunoassay and analyzed using the receiver operating characteristics (ROC) method.

RESULTS

The sensitivity and specificity of AFP and DCP for differentiating between early HCC and HBV-associated LC were 51.5% and 92.5%, and 60.0% and 84.7%, respectively. Comparative analysis of ROC curves showed no significant difference in the area under the curve (AUC) for AFP and DCP. Moreover, the combination of AFP and DCP showed the largest AUC value with a diagnostic sensitivity and specificity of 67% and 83.1%, respectively.

CONCLUSION

These results suggest that AFP is the best single biomarker for distinguishing between HBV-associated LC and early HCC induced by HBV. However, the combination of AFP and DCP can enhance the diagnostic value of AFP for differentiating between these diseases.

摘要

目的

本研究旨在探讨甲胎蛋白(AFP)、凝集素反应性 AFP(AFP-L3)和脱γ-羧基凝血酶原(DCP)不同组合在乙型肝炎病毒(HBV)相关肝硬化(LC)患者肝细胞癌(HCC)早期诊断中的应用。

方法

本研究共纳入 167 例患者,其中 HCC 患者 100 例,LC 患者 67 例。采用化学发光酶免疫分析法检测血清 AFP、AFP-L3 和 DCP 水平,并采用受试者工作特征(ROC)曲线分析。

结果

AFP 和 DCP 区分早期 HCC 和 HBV 相关 LC 的敏感性和特异性分别为 51.5%和 92.5%、60.0%和 84.7%。ROC 曲线比较分析显示,AFP 和 DCP 的曲线下面积(AUC)无显著差异。此外,AFP 和 DCP 联合检测的 AUC 值最大,诊断敏感性和特异性分别为 67%和 83.1%。

结论

这些结果表明,AFP 是区分 HBV 相关 LC 和 HBV 诱导的早期 HCC 的最佳单项生物标志物。然而,AFP 和 DCP 的联合检测可以提高 AFP 区分这些疾病的诊断价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/7604992/a743511069a7/10.1177_0300060519889270-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/7604992/12767e22959e/10.1177_0300060519889270-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/7604992/a743511069a7/10.1177_0300060519889270-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/7604992/12767e22959e/10.1177_0300060519889270-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/7604992/a743511069a7/10.1177_0300060519889270-fig2.jpg

相似文献

1
Diagnostic value of alpha-fetoprotein, agglutinin-reactive alpha-fetoprotein, and des-gamma-carboxyprothrombin in hepatitis B virus-related hepatocellular carcinoma.甲胎蛋白、凝集素反应性甲胎蛋白和去γ-羧基凝血酶原在乙型肝炎病毒相关肝细胞癌中的诊断价值。
J Int Med Res. 2020 Mar;48(3):300060519889270. doi: 10.1177/0300060519889270. Epub 2019 Dec 18.
2
Novel Lens culinaris agglutinin-reactive fraction of α-fetoprotein: a biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations.新型刀豆球蛋白 A 反应性α-甲胎蛋白片段:低甲胎蛋白浓度肝癌患者肝癌复发的生物标志物。
Int J Clin Oncol. 2012 Aug;17(4):373-9. doi: 10.1007/s10147-011-0306-3. Epub 2011 Aug 17.
3
Evaluation of serum AFP and DCP levels in the diagnosis of early-stage HBV-related HCC under different backgrounds.不同背景下血清甲胎蛋白(AFP)和异常凝血酶原(DCP)水平在早期乙肝相关肝细胞癌诊断中的评估
J Int Med Res. 2020 Oct;48(10):300060520969087. doi: 10.1177/0300060520969087.
4
Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma.单独或联合使用甲胎蛋白的豆凝集素反应性组分和去γ-羧基凝血酶原作为肝细胞癌生物标志物的效用。
Clin Gastroenterol Hepatol. 2009 Jan;7(1):104-13. doi: 10.1016/j.cgh.2008.08.041. Epub 2008 Sep 17.
5
Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol.甲胎蛋白、扁豆凝集素结合型甲胎蛋白、脱γ羧基凝血酶原和甘胆酸 3 用于肝细胞癌检测的诊断性能:系统评价和荟萃分析方案。
Syst Rev. 2013 Jun 6;2:37. doi: 10.1186/2046-4053-2-37.
6
Clinical utility of simultaneous measurement of serum high-sensitivity des-gamma-carboxy prothrombin and Lens culinaris agglutinin A-reactive alpha-fetoprotein in patients with small hepatocellular carcinoma.同时检测血清高灵敏度去γ-羧基凝血酶原和刀豆球蛋白A反应性甲胎蛋白在小肝细胞癌患者中的临床应用价值
Eur J Gastroenterol Hepatol. 1999 Dec;11(12):1387-92. doi: 10.1097/00042737-199912000-00008.
7
Des-γ carboxyprothrombin may not be a good biomarker for hepatocellular carcinoma in those chronically infected with hepatitis B virus with basal core promoter double mutations (T^{1762}, A^{1764}), a prospective study.对于慢性感染乙型肝炎病毒且存在核心启动子双突变(T¹⁷⁶²,A¹⁷⁶⁴)的患者,去γ羧基凝血酶原可能并非肝细胞癌的良好生物标志物,一项前瞻性研究。
Cancer Biomark. 2017;18(3):241-248. doi: 10.3233/CBM-160131.
8
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.慢性肝炎、肝硬化和肝细胞癌患者的去γ-羧基凝血酶原、甲胎蛋白和甲胎蛋白-L3
J Gastroenterol Hepatol. 2008 Oct;23(10):1541-8. doi: 10.1111/j.1440-1746.2008.05395.x. Epub 2008 Apr 19.
9
AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation.AFP-L3 和 DCP 强烈预测肝移植后早期肝细胞癌复发。
J Hepatol. 2023 Dec;79(6):1469-1477. doi: 10.1016/j.jhep.2023.08.020. Epub 2023 Sep 7.
10
Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.在中国,去γ-羧基凝血酶原与甲胎蛋白对乙型肝炎病毒相关肝细胞癌的诊断评估:一项大规模、多中心研究
PLoS One. 2016 Apr 12;11(4):e0153227. doi: 10.1371/journal.pone.0153227. eCollection 2016.

引用本文的文献

1
Hepatocellular Carcinoma: The Search for an Optimal Screening Test.肝细胞癌:寻找最佳筛查检测方法
Middle East J Dig Dis. 2025 Jan;17(1):31-39. doi: 10.34172/mejdd.2025.407. Epub 2025 Jan 31.
2
Combination of serum alpha-fetoprotein, PIVKA-Ⅱ and glypican-3 in diagnosis of hepatocellular carcinoma: a meta-analysis.血清甲胎蛋白、异常凝血酶原和磷脂酰肌醇聚糖蛋白 3 联合检测在肝细胞癌诊断中的价值:一项荟萃分析。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Feb 1;53(1):131-139. doi: 10.3724/zdxbyxb-2023-0483.
3
HepaClear, a blood-based panel combining novel methylated CpG sites and protein markers, for the detection of early-stage hepatocellular carcinoma.

本文引用的文献

1
Hepatocellular Carcinoma.肝细胞癌
N Engl J Med. 2019 Apr 11;380(15):1450-1462. doi: 10.1056/NEJMra1713263.
2
Treatment Strategies for Hepatocellular Carcinoma ⁻ a Multidisciplinary Approach.肝细胞癌的治疗策略 ⁇ 多学科方法。
Int J Mol Sci. 2019 Mar 22;20(6):1465. doi: 10.3390/ijms20061465.
3
Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage.甲胎蛋白阴性肝癌的生物标志物现状与展望:迈向早期肝细胞癌的筛查与诊断
HepaClear,一种基于血液的panel,结合了新型甲基化 CpG 位点和蛋白质标志物,用于检测早期肝细胞癌。
Clin Epigenetics. 2023 Jun 12;15(1):99. doi: 10.1186/s13148-023-01508-7.
4
Diagnostic Performance of Extrahepatic Protein Induced by Vitamin K Absence in the Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.维生素K缺乏诱导的肝细胞癌肝外蛋白的诊断性能:一项系统评价和荟萃分析
Diagnostics (Basel). 2023 Feb 21;13(5):816. doi: 10.3390/diagnostics13050816.
5
A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma.一项关于 AFP、DCP 和 GP73 等 11 种血液生物标志物在肝细胞癌诊断中的临床价值的荟萃分析。
Ann Med. 2023 Dec;55(1):42-61. doi: 10.1080/07853890.2022.2153163.
6
Viral Diagnosis of Hepatitis B and Delta: What We Know and What Is Still Required? Specific Focus on Low- and Middle-Income Countries.乙型肝炎和丁型肝炎的病毒诊断:我们所知与仍需了解的内容?特别关注低收入和中等收入国家
Microorganisms. 2022 Oct 22;10(11):2096. doi: 10.3390/microorganisms10112096.
7
Performance evaluation of the Elecsys PIVKA-II and Elecsys AFP assays for hepatocellular carcinoma diagnosis.用于肝细胞癌诊断的Elecsys PIVKA-II和Elecsys AFP检测的性能评估。
JGH Open. 2022 May 7;6(5):292-300. doi: 10.1002/jgh3.12720. eCollection 2022 May.
8
Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.腹部超声和甲胎蛋白检测用于诊断慢性肝病成人的肝细胞癌。
Cochrane Database Syst Rev. 2021 Apr 15;4(4):CD013346. doi: 10.1002/14651858.CD013346.pub2.
9
Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development.慢性病毒性肝炎期间的促纤维化信号与肝癌风险:生物标志物的开发
J Clin Med. 2021 Mar 2;10(5):977. doi: 10.3390/jcm10050977.
Pathol Oncol Res. 2020 Apr;26(2):599-603. doi: 10.1007/s12253-019-00585-5. Epub 2019 Jan 19.
4
Evaluation of Serum Des-Gamma-Carboxy Prothrombin for the Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Meta-Analysis.血清γ-羧基凝血酶原在乙型肝炎病毒相关肝细胞癌诊断中的评价:一项荟萃分析。
Dis Markers. 2018 Oct 4;2018:8906023. doi: 10.1155/2018/8906023. eCollection 2018.
5
Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early-Stage Hepatocellular Carcinoma.三种血清生物标志物用于早期检测肝细胞癌的纵向评估。
Hepatology. 2019 May;69(5):1983-1994. doi: 10.1002/hep.30233. Epub 2019 Feb 20.
6
Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma.五种血清生物标志物在肝细胞癌早期诊断中的直接比较
Cancer Manag Res. 2018 Jul 10;10:1947-1958. doi: 10.2147/CMAR.S167036. eCollection 2018.
7
Patterns and Trends of Liver Cancer Incidence Rates in Eastern and Southeastern Asian Countries (1983-2007) and Predictions to 2030.东亚和东南亚国家肝癌发病率的模式和趋势(1983-2007 年)以及到 2030 年的预测。
Gastroenterology. 2018 May;154(6):1719-1728.e5. doi: 10.1053/j.gastro.2018.01.033. Epub 2018 Mar 14.
8
Temporal improvement in survival of patients with hepatocellular carcinoma in a hepatitis B virus-endemic population.乙型肝炎病毒流行地区肝细胞癌患者的生存时间得到改善。
J Gastroenterol Hepatol. 2018 Feb;33(2):475-483. doi: 10.1111/jgh.13848.
9
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.EASL 2017 临床实践指南:乙型肝炎病毒感染管理。
J Hepatol. 2017 Aug;67(2):370-398. doi: 10.1016/j.jhep.2017.03.021. Epub 2017 Apr 18.
10
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.